Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...
ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.
Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...
The pelvis is often called the keystone of upright movement. It helps explain how human ancestors left life on all fours ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
Researchers identify altered expression of genes that worsens periodontitis among smokers, and a new target molecule ...
The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...
Research led by the SickKids Research Institute in Toronto and the University of Pennsylvania, has found that immune-related ...
Dr Anna Wilkins’ group is investigating how to target the tumour microenvironment of bladder and prostate cancer to prevent treatment resistance, especially to radiation given with curative intent.